In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...

Researchers developed synthetic receptors on the surface of immune cells that could make cancer immunotherapies more targeted.

Prostate cancer hijacks the normal prostate's growth regulation program to release the brakes and grow freely, according to ...

近日，NEJM上发表的一种新型免疫疗法TCR-T疗法引起轰动！原文题目为“Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer”。一位转移性胰腺癌晚期患者（KRAS ...

A once-a-day tablet for advanced breast cancer will be rolled out on the NHS. More than 1,000 women will be eligible for the ...

A new paper from MUSC Hollings Cancer Center researchers is helping to reveal the "rules" for engineering chimeric antigen ...

Prostate cancer hijacks the normal prostate's growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers.

Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, ...

Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat.

New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...

Imlunestrant worked particularly well in combination with the targeted therapy drug Verzenio. The combo helped women with ...